ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

595 hedge funds and large institutions have $30B invested in Alexion Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 218 increasing their positions, 214 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

2% more repeat investments, than reductions

Existing positions increased: 218 | Existing positions reduced: 214

0% more funds holding in top 10

Funds holding in top 10: 1919 (0)

Holders
595
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
19
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$551M
Puts
$435M
Net Calls
Net Calls Change

Top Buyers

1 +$657M
2 +$121M
3 +$86.4M
4
UBS AM
UBS AM
Illinois
+$71.3M
5
Alkeon Capital Management
Alkeon Capital Management
New York
+$70.1M

Top Sellers

1 -$339M
2 -$220M
3 -$189M
4
State Street
State Street
Massachusetts
-$85M
5
BlackRock
BlackRock
New York
-$79.8M
Name Holding Trade Value Shares
Change
Change in
Stake
351
$1.13M
352
$1.12M
353
$1.11M
354
$1.08M
355
$1.06M
356
$1.04M
357
$960K
358
$958K
359
$944K
360
$938K
361
$935K
362
$925K
363
$923K
364
$914K
365
$906K
366
$892K
367
$884K
368
$878K
369
$866K
370
$861K
371
$855K
372
$854K
373
$842K
374
$833K
375
$822K